Drugs from Ranbaxy India plants banned from US until fixes confirmed
This article was originally published in Scrip
Executive Summary
Indian drug maker Ranbaxy will be banned from manufacturing drugs at certain plants for the US market and for the President's Emergency Plan for AIDS Relief programme, which supplies medicines to developing nations to treat HIV/AIDS, until the company corrects violations and ensures a series of ongoing problems at those facilities never happen again, US regulators and prosecutors said.